Department of Biology and Bioinformatics Program, Boston University, Boston, Massachusetts 02215.
Toxicol Sci. 2017 Sep 1;159(1):25-41. doi: 10.1093/toxsci/kfx114.
Xenobiotic agonists of constitutive androstane receptor (CAR) induce many hepatic drug metabolizing enzymes, but following prolonged exposure, promote hepatocellular carcinoma, most notably in male mouse liver. Here, we used nuclear RNA-seq to characterize global changes in the mouse liver transcriptome following exposure to the CAR-specific agonist ligand 1,4-bis-[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP), including changes in novel long noncoding RNAs that may contribute to xenobiotic-induced pathophysiology. Protein-coding genes dysregulated by 3 h TCPOBOP exposure were strongly enriched in KEGG pathways of xenobiotic and drug metabolism, with stronger and more extensive gene responses observed in female than male liver. After 27 h TCPOBOP exposure, the number of responsive genes increased >8-fold in males, where the top enriched pathways and their upstream regulators expanded to include factors implicated in cell cycle dysregulation and hepatocellular carcinoma progression (cyclin-D1, oncogenes E2f, Yap, Rb, Myc, and proto-oncogenes β-catenin, FoxM1, FoxO1, all predicted to be activated by TCPOBOP in male but not female liver; and tumor suppressors p21 and p53, both predicted to be inhibited). Upstream regulators uniquely associated with 3 h TCPOBOP-exposed females include TNF/NFkB pathway members, which negatively regulate CAR-dependent proliferative responses and may contribute to the relative resistance of female liver to TCPOBOP-induced tumor promotion. These responses may be modified by the many long noncoding liver RNAs we show are dysregulated by TCPOBOP or pregnane-X-receptor agonist exposure, including lncRNAs proximal to CAR target genes Cyp2b10, Por, and Alas1. These data provide a comprehensive view of the CAR-regulated transcriptome and give insight into the mechanism of sex-biased susceptibility to CAR-dependent mouse liver tumorigenesis.
外源性化学物质激活型细胞色素 P450 受体(CAR)诱导许多肝药物代谢酶,但长期暴露后会促进肝细胞癌,尤其是在雄性小鼠肝脏中。在这里,我们使用核 RNA-seq 技术来描述暴露于 CAR 特异性激动剂配体 1,4-双-[2-(3,5-二氯吡啶氧基)]苯(TCPOBOP)后,小鼠肝转录组的全局变化,包括可能有助于外源性化学物质诱导的病理生理学的新型长非编码 RNA 的变化。3 h TCPOBOP 暴露引起的蛋白编码基因失调在 KEGG 外源性化学物质和药物代谢途径中强烈富集,在雌性肝脏中观察到更强和更广泛的基因反应。27 h TCPOBOP 暴露后,雄性肝脏中响应基因的数量增加了 8 倍以上,其中富集的途径及其上游调节剂扩展到包括细胞周期失调和肝细胞癌进展相关的因素(细胞周期蛋白 D1、癌基因 E2f、Yap、Rb、Myc 和原癌基因β-catenin、FoxM1、FoxO1,所有这些基因都预测在雄性肝脏中被 TCPOBOP 激活,但在雌性肝脏中没有;肿瘤抑制因子 p21 和 p53,都预测被 TCPOBOP 抑制)。与 3 h TCPOBOP 暴露的雌性相关的唯一上游调节剂包括 TNF/NFkB 途径成员,它们负调控 CAR 依赖性增殖反应,可能有助于雌性肝脏对 TCPOBOP 诱导的肿瘤促进的相对抗性。我们发现许多长非编码肝 RNA 被 TCPOBOP 或孕烷 X 受体激动剂暴露所失调,包括靠近 CAR 靶基因 Cyp2b10、Por 和 Alas1 的 lncRNA,这些反应可能会被修饰。这些数据提供了 CAR 调节转录组的全面视图,并深入了解了 CAR 依赖性小鼠肝肿瘤发生中性别偏向易感性的机制。